Barclays PLC
NYSE:BCSBanks - Diversified
+$0.12 today
- Market cap
- $72.23B
- Beta
- 0.90
- P/E (TTM)
- 9.5
- EPS (TTM)
- $0.53
- Dividend yield
- 1.72%
Volume 4.84M
Average 6.73M
BCS EBITDA Margin
EBITDA as a percentage of revenue.
Barclays PLCNYSE: BCS
EBITDA Margin · Q3 FY2026 · quarter ended Sep 2026
EBITDA Margin holds steady near 31.3%
EBITDA Margin was 31.3% in Q3 FY2026, up 0.3 pp from a year earlier. On a trailing-twelve-month basis it was 33.4%, up 1.8 pp year over year. Over 3 fiscal years it narrowed by 4.9 pp.
Context
- EBITDA Margin widened in 2 of the last 3 fiscal years.
What to watch
Whether EBITDA Margin reaches the consensus estimate from 9 analysts of 42.2% for the fiscal year ending Dec 2026, up from 21.4% in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterSep 2026
- 31.3%-7.7 pp QoQ
- Last fiscal yearDec 2025
- 21.4%+4.0 pp YoY
- LTMSep 2026
- 33.4%+1.8 pp YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +0.3 pp | +4.2 pp | +3.9 pp |
| 1 year | +4.0 pp | +20.8 pp | +16.8 pp |
| 3 years | -4.9 pp | +31.5 pp | +36.4 pp |
| 5 years | +39.5 pp | — | |
| 10 years | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- 21.4%
- Year-over-year change
- +4.0pp
| Period | Period end | EBITDA Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 21.4% | +4.0pp |
| FY2024 | 2024-12-31 | 17.4% | +0.9pp |
| FY2023 | 2023-12-31 | 16.6% | -9.7pp |
| FY2022 | 2022-12-31 | 26.3% | -13.0pp |
| FY2021 | 2021-12-31 | 39.3% | — |
EBITDA Margin vs competitors
How BCS compares with its peers on the latest reported figures
- BCS's LTM Sep 2026 EBITDA Margin of 33.4% is the 2nd highest of the 9 companies compared; the peer median is 23.4%.
- Its year-over-year change of +1.8 pp is the 5th highest of 9, against a peer median of +1.9 pp.
- Over three fiscal years its change of -4.9 pp compares with a peer median of -6.6 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Jun 2026 | 38.0% | -0.8 pp | +19.3 pp | |
| LTM Sep 2026 | 33.4% | +1.8 pp | -4.9 pp | |
| LTM Sep 2026 | 30.6% | +1.3 pp | -5.5 pp | |
| LTM Jun 2026 | 29.5% | +8.8 pp | -1.5 pp | |
| LTM Jun 2026 | 23.4% | -5.8 pp | -2.7 pp | |
| LTM Sep 2026 | 23.3% | +5.0 pp | -7.8 pp | |
| LTM Jul 2026 | 22.4% | +2.5 pp | -13.1 pp | |
| LTM Jul 2026 | 19.7% | -2.5 pp | -16.5 pp | |
| LTM Sep 2026 | 19.5% | +5.2 pp | -8.6 pp | |
| Peer median (excluding BCS) | 23.4% | +1.9 pp | -6.6 pp | |
Competitors are the stored peer set for BCS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 25.12B | 33.3B | 49.77B | 57.02B | 50.83B |
| Cost of Revenue | 3.17B | 9.75B | 23.91B | 27.96B | 21.69B |
| Gross Profit | 21.95B | 23.55B | 25.86B | 29.05B | 29.14B |
| Gross Margin | 87.4% | 70.7% | 52.0% | 51.0% | 57.3% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 1.97B | 10.95B | 11.77B | 11.94B | 2.73B |
| Operating Expenses | 13.76B | 16.52B | 19.4B | 20.81B | 20B |
| Depreciation & Amortization | 1.67B | 1.72B | 1.78B | 1.7B | 1.76B |
| EBITDA | 9.87B | 8.76B | 8.24B | 9.94B | 10.9B |
| EBITDA Margin | 39.3% | 26.3% | 16.6% | 17.4% | 21.4% |
| Operating Income | 8.19B | 7.04B | 6.45B | 8.28B | 9.14B |
| Operating Margin | 32.6% | 21.1% | 13.0% | 14.5% | 18.0% |
| Interest Income | 11.24B | 19.21B | 34.5B | 39.14B | 36.19B |
| Interest Expense | 3.17B | 8.56B | 22B | 25.93B | 21.69B |
| Other Income / Expenses | 0 | (6.03M) | 8.85M | (37.78M) | 0 |
| Income Before Tax | 8.19B | 7.04B | 6.46B | 8.24B | 9.14B |
| Pre-Tax Margin | 32.6% | 21.1% | 13.0% | 14.5% | 18.0% |
| Income Tax Expense | 1.14B | 1.04B | 1.21B | 1.79B | 1.93B |
| Net Income | 7.01B | 5.95B | 5.17B | 6.44B | 7.17B |
| Net Margin | 27.9% | 17.9% | 10.4% | 11.3% | 14.1% |
| EPS (Basic) | 1.48 | 1.24 | 1.12 | 1.44 | 1.80 |
| EPS (Diluted) | 1.44 | 1.20 | 1.08 | 1.40 | 1.80 |
| Weighted Avg Shares | 4.25B | 4.08B | 3.86B | 3.69B | 3.45B |
| Weighted Avg Shares (Diluted) | 4.36B | 4.22B | 3.97B | 3.82B | 3.45B |
Barclays PLC
NYSE:BCS
Intrinsic Alpha fair value
Locked
Current Price
$21.60
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.